Advances in AI and digital technologies have the potential to create significant impact across pharmaceutical R&D, especially in CMC where they can accelerate process development and tech transfer to commercial sites. This webinar focuses on key opportunities in process development and tech transfer. The presenters discuss how advancements in AI and digital technologies can facilitate innovation across drug substance and drug product development, enable more facile and efficient tech transfer, streamline document authoring and encourage cross-functional knowledge sharing and collaboration.
Watch this webinar to learn how:
- Digital solutions can be used to bring more efficiency to tech transfer and reduce the time needed for process validation
- The real-time streaming of PAT data can monitor processes and identify deviations
- Digital twins can be used to help evaluate the differences in outcomes across sites, optimize the process design space and accelerate tech transfer
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
